You are here: Home
Benefits of statin therapy may extend beyond lowering lipids

Benefits of statin therapy may extend beyond lowering lipids

People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation ...

Treating Cancer with Light

Treating Cancer with Light

New LED Device May Help Advance Photodynamic Therapy for Skin Cancer. Scientists at the University of California, Irvine (UC Irvine), believe so. They're explo...

Exploring Opportunities in Chemical Biology

Interview with: Torsten Hoffmann, Head Discovery Chemistry, F. Hoffmann – La Roche
Drug discovery scientists need to broaden their approaches to pharmaceutical...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

News

Aspirin may fight cancer by slowing DNA

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin

Wednesday, 19 June 2013 Comments

Press Releases

Obesity is a Disease: The American Medical Association Agrees with the American Association of Clinical

The American Association of Clinical Endocrinologists (AACE) applauds the American Medical Association (AMA) House of Delegates for its action today to approve a resolution recognizing obesity as a disease state

Wednesday, 19 June 2013 Comments

Research Insight

IMI Builds Collaborations to Monitor Vaccine Safety and Drug

The Innovative Medicines Initiative (IMI) is calling experts to join forces and tackle two challenges which are of major importance to public

Friday, 20 July 2012 Comments

Techno Trends

LabCorp Announces Availability of Newly Approved Viral Load Assay for Hepatitis C

Laboratory Corporation of America® Holdings today announced that it is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test v2.0. With enhanced sensitivity this quantitative viral load assay for Hepatitis C virus

Tuesday, 18 June 2013 Comments

Industry Reports

Adocia announces its Q1 2013

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today its Q1 2013 re

Friday, 26 April 2013 Comments

Articles

Oncology Treatment Adherence: Understanding the Patient

It would be easy to assume that an oral treatment that can halt the progression of a rare form of leukaemia would have high rates of adherence.

Tuesday, 14 August 2012 Comments

Business & Industry

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

Drug Research

Takeda announces availability of type 2 diabetes drugs in

Takeda Pharmaceutical Company has announced the availability of NESINA (alogliptin) and fixed-dose combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) by prescription in the

Tuesday, 18 June 2013 Comments

Production & Manufacturing

Aspen proposes to acquire GSK's thrombosis brands and NDB

Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) has received a proposal from Aspen Global and Aspen Pharmacare Holdings for its thrombosis brands and Notre-Dame de Bondeville (NDB)

Wednesday, 19 June 2013 Comments

Packaging & Labelling

Canada unveils new labeling initiative to enhance drug

Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier to read and understand for all

Monday, 17 June 2013 Comments

Strategy

OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, today announced it has expanded its collaboration with Bayer HealthCare. Bayer’s U.S. affiliate will manufacture clinical supplies of

Saturday, 21 July 2012 Comments

Clinical Trials

Eli Lilly reports positive data from Phase III study of

Eli Lilly and Company has reported positive data from the Phase III study of Cialis/finasteride in men with lower urinary tract symptoms of benign prostatic hyperplasia (LUTS/BPH) and enlarged pr

Tuesday, 19 March 2013 Comments

IT & Data Management

RaySearch unveils new version of RayStation treatment planning

RaySearch Laboratories has launched a new version of its RayStation treatment planning system for clinical use in the European Union, the US, Japan and Au

Tuesday, 19 March 2013 Comments

Banner